ArticleJAMA oncology2026

Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.

Niamh Cunningham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.